Biomeme

Biomeme develops and commercializes mobile molecular diagnostic platforms that enable rapid, accurate DNA/RNA testing at the point of need. Their flagship products transform smartphones into portable labs using PCR technology. The company’s next-generation “Host Response” platform uses immune signatures to rapidly distinguish between bacterial, viral, and fungal infections. Their solutions are used by healthcare providers, researchers, military personnel, and first responders for infectious disease surveillance and biodefense. During the COVID pandemic they scaled up manufacturing of rapid PCR devices. Early results show promise in improving antimicrobial stewardship by reducing unnecessary antibiotic prescriptions.